China has initiated human testing of implantable brain-computer interface (BCI) devices, signaling its commitment to advancing BCI technology. Concurrently, Australian startup Cortical Labs has launched the CL1, the world's first code-deployable biocomputer powered by 800,000 lab-grown human neurons interfaced on a silicon chip. The CL1 is priced at $35,000 per unit, with a cloud-based version available for $300 per week, and 115 units are scheduled to ship this summer. This development marks a milestone in computational technology and has potential implications for neuroscience and drug discovery. Additionally, China is integrating BCI into its medical payment system, demonstrating a practical application of the technology. Meanwhile, Neuralink has raised $650 million to advance brain-computer chips aimed at improving healthcare.
🔥 WORLD'S FIRST BIOCOMPUTER, POWERED BY HUMAN BRAIN CELLS ON A SILICON CHIP Cortical Labs released CL1, a bio-computer using 800,000 lab-grown human neurons interfaced on a silicon chip. Each chip costs $35,000, with a cloud version at $300 per week. sub-ms response, remote https://t.co/UKFK42QSKP
#OpinionLine #China's move to integrate brain-computer interface (BCI) into its medical payment system is a signal to the world that it is not just talking about the future, but underwriting it. #BCI #tech https://t.co/7TFytySOR3 https://t.co/lEA1XOQhkE
A look at Australian startup Cortical Labs' CL1, billed as the first code-deployable biological computer, with 115 units shipping this summer at $35K each (@shannoncuthrell / IEEE Spectrum) https://t.co/2uIywXluxC https://t.co/twO1sxODi4 https://t.co/ZOzeer1FAj